News

16 Oct 2014

Co-founder of the Institute for Research in Biomedicine (IRB Barcelona) and Chair of its External Advisory Board, Joan Massagué, has been awarded the Spanish National Research Award for 2014, in th

13 Oct 2014

Today the Institute for Research in Biomedicine (IRB Barcelona) has launched an innovative video ­– featuring its scientists as dancers.

8 Oct 2014

Researchers at the Institute for Research in Biomedicine (IRB Barcelona) have managed to generate a fruit fly (Drosophila melanogaster) model that reproduces human colon cancer.

3 Oct 2014

The award is an important recognition to the project and the research conducted by the team of Iproteos.

Media mentions

08 Oct 2014

Most Dangerous Aggregates in Alzheimer's Identified

GEN - Genetic Engineering and Biotechnology News

The North American journal GEN reports on research performed by Natàlia Carulla, with the Peptides and Proteins Group at IRB, on beta-amyloid aggregates and their relation with Alzheimer’s disease. The study concludes that the most harmful aggregates for neurons are intermediate accumulations of beta-amyloid, these ranging from between 20 and 100 units.

Edit link:
08 Oct 2014

Drug for schizophrenia receives a prize

El Mundo Catalunya

IProteos, a spin-off from IRB Barcelona labs and co-funded by the researchers Teresa Tarragó and Ernest Giralt, has received the prize Expoquimia R+D+I for a new drug under development for the treatment of schizophrenia.

Edit link:
08 Oct 2014

Investing in the future

TV3

The scientific reporter Pere Estupinyà talks to representatives from business, research, political and educational circles to find out whether Catalonia is prepared for a production model based on the generation of knowledge. Estupinyà also visits labs at IRB Barcelona, at the Barcelona Science Park, where he speaks to Joan J Guinovart, director of the centre.

Edit link:

Photo gallery

Contact

Sònia Armengou
Media Relations Officer
Tel: +34 93 40 37255

Quick facts about IRB

Quick facts

IRB Barcelona is home to nearly 450 research, technical and support staff from 35 countries who share the common goal of contributing to the advancement of the biomedical sciences through investigator–driven research, and improving quality of life by applying advances in this field.

The convergence of biology, chemistry, and structural and computational biology is unique at IRB Barcelona and opens a strategic window to gain insight into basic molecular processes in health and disease.

Research is conducted by 23 groups organized into 5 interdisciplinary programmes. Each programme includes a diverse faculty of researchers with overlapping scientific interests. The research areas have been structured to be highly interactive, fostering multidisciplinarity by combining modern molecular biology, classical genetics, biochemistry, structural biology, bioinformatics, systems biology, advanced microscopy, and genomic and proteomic approaches.

Our Board of Trustees comprises members of the Catalan Government (from the Department of Economy and Competitivity and the Department of Health), the University of Barcelona, a representative from the BBVA Foundation as well as internationally renowned scientists.

IRB Barcelona is housed within the Barcelona Science Park on the University of Barcelona Pedralbes Campus. It is an integral part of the ‘Bioregion of Catalonia’, a rich landscape of research centres of excellence, universities, science parks, hospitals, scientific infrastructures and pharmaceutical companies, all with a focus on the life sciences. It is a member of the CERCA network of government research centres.